You.com Announces Partnership with Boardwave To Bring AI-Powered Productivity To The European Software Industry
You.com, an AI-powered productivity engine, and Boardwave, a prominent community for 1,700+ European software leaders, have today announced a joint partnership to accelerate productivity and the adoption of AI in the European software industry.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240918041701/en/
You.com, an AI-powered productivity engine, and Boardwave, a prominent community for 1,700+ European software leaders, have today announced a joint partnership to accelerate productivity and the adoption of AI in the European software industry. (Graphic: Business Wire)
The new collaboration launches today at Boardwave Live in London and offers each of Boardwave’s members, and their leadership teams, access to You.com’s Team plan. This initiative equips European software entrepreneurs, founders, and CEOs with an all-in-one conversational AI platform for enhancing human productivity.
You.com offers access to the latest and most powerful Large Language Models (LLMs), enhanced with live web access. The platform features a range of powerful proprietary AI agents for research and problem-solving and the ability to create and share custom agents on top of any AI model for any task.
“Partnering with Boardwave is a great opportunity to get our AI into the hands of Europe’s software leaders. We’ve built You.com to tackle real productivity challenges. It’s not only about having the latest AI models; it’s about making them genuinely useful and trustworthy. Our APIs have been particularly popular in the SaaS community, allowing companies to integrate our AI capabilities directly into their workflows. We’re looking forward to partnering with Boardwave members to put these tools to work in their companies,” said Bryan McCann, CTO and co-founder of You.com, at the Boardwave Live event.
Boardwave Live is Boardwave’s Annual Conference, which draws together 450 of the best and brightest software Founders, CEOs, NEDs and Chairs from across Europe. During 2024, Boardwave has actively focussed on the use of “Practical AI” and how it can better support its community, using partnerships, events, mentorships and masterclasses. The partnership with You.com takes this to a deeper level and provides each of Boardwave’s members, and their executive teams, with access to all the popular LLMs.
“At Boardwave, we’re committed to accelerating the growth of European software companies. By partnering with You.com, we’re providing our members with access to an amazing toolkit of state-of-the-art AI, and all the major LLMS, that can significantly enhance their productivity. You.com’s offering includes access to all the latest AI models, best-in-class citations, reduced hallucinations, and improved accuracy, resulting in a more trustworthy experience. It’s a platform built by AI pioneers, and we’re excited to see how it will empower our community,” said Phill Robinson, CEO and co-founder of Boardwave.
For more information, visit www.you.com or www.boardwave.com.
For You.com’s APIs, visit https://you.com/business/api.
About You.com:
You.com is collaborative AI — for you, your team, and your business. You.com AI Agents maximize the productivity of knowledge workers through fast and accurate research and analysis, complex problem solving, content creation, and more. The company’s suite of APIs and end-to-end solutions drive revenue for businesses by becoming the foundation AI agent layer for their products and services. Founded by leading AI research scientists Richard Socher and Bryan McCann, You.com has raised $99 million from investors including Marc Benioff’s Time Ventures, Salesforce Ventures, NVIDIA, Gen Digital, SBVA, Georgian, Radical Ventures, Day One Ventures, Breyer Capital, Norwest Venture Partners, DuckDuckGo, Untapped Ventures, and others.
About Boardwave:
Boardwave is an impact-driven community of 1,700 European software founders and CEOs designed to help members accelerate their business growth, and to improve the overall position of Europe as a home for global software companies. Boardwave offers a programme of events, peer-to-peer mentoring and inspiration, as well as an online platform that connects European software CEOs for advice, insights, expertise and access to capital. It is also a campaigner for change across special interest areas including AI, Government engagement and DE&I. Software leaders, CEOs, NEDs and Chairs can access the programme and platform at no cost. The Boardwave community is generously supported and funded by a network of 85+ Partners from across the software investor and advisory ecosystem. www.boardwave.org
View source version on businesswire.com: https://www.businesswire.com/news/home/20240918041701/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom